Загрузка...
Reversible Posterior Leukoencephalopathy Syndrome Developing After Restart of Sunitinib Therapy for Metastatic Renal Cell Carcinoma
A 64-year-old Japanese man had started molecular-targeted therapy with sunitinib for lymph node metastasis 5 years after nephrectomy for left renal cell carcinoma (clear cell carcinoma, G2, pT2N0M0). He was transported to our emergency department because of generalized tonic-clonic seizure, vision l...
Сохранить в:
Опубликовано в: : | Case Rep Med |
---|---|
Главные авторы: | , , , , |
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
Hindawi Publishing Corporation
2016
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5067324/ https://ncbi.nlm.nih.gov/pubmed/27795711 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6852951 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|